ArticleOxford medical case reports2026
Squamous cell carcinoma arising in mature ovarian teratoma: a rare clinical entity.
Article in Oxford medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squamous cell carcinoma (SCC) of the ovary is a rare malignancy, most commonly arising from malignant transformation within a mature cystic teratoma (MCT). The incidence of such transformation is estimated at around 2%. We report the case of a postmenopausal woman who initially underwent resection of a pelvic mass with right adnexectomy. Histopathological examination revealed squamous cell carcinoma arising in a mature ovarian teratoma. The case was subsequently discussed at a multidisciplinary tumor board, which recommended completion surgery. However, during the planned procedure, diffuse peritoneal carcinomatosis was discovered intraoperatively. The patient was therefore referred for neoadjuvant chemotherapy. This case highlights the diagnostic and therapeutic challenges of SCC arising in MCT, as well as its aggressive clinical course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.